Inhibition of cargo export at ER exit sites and the trans-Golgi network by the secretion inhibitor FLI-06

J Cell Sci. 2016 Oct 15;129(20):3868-3877. doi: 10.1242/jcs.186163. Epub 2016 Sep 1.

Abstract

Export out of the endoplasmic reticulum (ER) involves the Sar1 and COPII machinery acting at ER exit sites (ERES). Whether and how cargo proteins are recruited upstream of Sar1 and COPII is unclear. Two models are conceivable, a recruitment model where cargo is actively transported through a transport factor and handed over to the Sar1 and COPII machinery in ERES, and a capture model, where cargo freely diffuses into ERES where it is captured by the Sar1 and COPII machinery. Using the novel secretion inhibitor FLI-06, we show that recruitment of the cargo VSVG to ERES is an active process upstream of Sar1 and COPII. Applying FLI-06 before concentration of VSVG in ERES completely abolishes its recruitment. In contrast, applying FLI-06 after VSVG concentration in ERES does not lead to dispersal of the concentrated VSVG, arguing that it inhibits recruitment to ERES as opposed to capture in ERES. FLI-06 also inhibits export out of the trans-Golgi network (TGN), suggesting that similar mechanisms might orchestrate cargo selection and concentration at the ER and TGN. FLI-06 does not inhibit autophagosome biogenesis and the ER-peroxisomal transport route, suggesting that these rely on different mechanisms.

Keywords: COP II; ER exit sites; ER export; Secretion; Secretory pathway; Trans-Golgi network; VSVG.

MeSH terms

  • Autophagosomes / drug effects
  • Autophagosomes / metabolism
  • Endocytosis / drug effects
  • Endoplasmic Reticulum / metabolism*
  • Exocytosis / drug effects
  • HeLa Cells
  • Humans
  • Peroxisomes / drug effects
  • Peroxisomes / metabolism
  • Protein Folding / drug effects
  • Protein Transport / drug effects
  • Quinolines / pharmacology*
  • trans-Golgi Network / drug effects
  • trans-Golgi Network / metabolism*

Substances

  • Quinolines
  • cyclohexyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate